News items Vidi-subsidie voor vier Radboud onderzoekers
30 May 2017

Four researchers from Nijmegen – three from Radboudumc and one from Radboud University – are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.

Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20% in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.

Three researchers at the Radboudumc will receive a Vidi grant: Dr Ir Sita Vermeulen, Dr Vivian Weerdesteyn and Dr Christian Gilissen. In addition, one researcher from the Radboud University has also been awarded a Vidi grant: Dr Hanneke den Ouden. Information about the scientists and their research is given below.

Researchers at the Radboudumc

Matching therapy and bladder cancer patient Sita Vermeulen Radboudumc – Health Evidence
A good therapy choice in non-muscle invasive bladder cancer requires a test that can predict who will and who will not respond to immunotherapy. The researchers measure changes in the genes of the patient and the bladder tumor to facilitate the development of such a test.

Roads to Recovery                                                 
Dr. Vivian Weerdesteyn, Radboudumc – Kinesiology / Rehabilitation medicine                                              
It is yet unknown how various pathways in the brain interact in recovering balance and gait abilities after stroke. The researchers aim to provide insight into this matter. In addition, they will study whether a new training program may enhance balance and gait control, and thereby functioning in daily life.

Integrating Metabolomics and Genomics for understanding human Disease
Dr. Christian Gilissen, Radboudumc – Human Genetics
The identification of disease-causing errors in the DNA is difficult and provides us with limited insights into the workings of the disease. Through bioinformatics methods and data integration of metabolite and DNA data I will improve the identification of genetic causes of disease and find novel leads for therapies.

Researcher at the Radboud University
Getting things done: finding the balance between deciding fast, and deciding well
Dr. Hanneke den Ouden, Radboud University - Donders Institute for Brain, Cognition and Behaviour
"Don't rush decisions!" Good advice, but too much deliberation can lead to missed opportunities. Hanneke Den Ouden will investigate how our brains help us switch between impulsive and thoughtful decision-making strategies. Furthermore, she will research how getting stuck in one particular strategy may be related to negative consequences such as addiction and burn-out.

Read the press release by NWO here

Related news items

Teacher of the year award for Scott Maurits

18 June 2019

On 11 June Scott Maurits received the Teacher of the Year award for a second year in a row. According to the students Scott won by being an inspirational teacher in statistics.

read more

Radboudumc Master Prize for Mark van Goor

18 June 2019

Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, USA.

read more

Experiences with molecular tumor boards

18 June 2019

In British Journal of Cancer Annelieke Willemsen, Carla van Herpen and colleagues showed that MTBs may have an important impact on patient care, but challenges remain for the accessibility for cancer patients.

read more

Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies

18 June 2019

Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.

read more

Lowering cholesterol is not enough to reduce hyperactivity of the immune system

14 June 2019

In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.

read more

New cause for vaginal yeast infections discovered

13 June 2019

Martin Jaeger, theme Infectious diseases and global health, and colleagues, identified SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Their findings were published in Science Translational Medicine.

read more